Wireless Based Monitoring and Diagnostics
| Publication Date | July 2006 |
|---|---|
| Publisher | Wireless Healthcare |
| Product Type | Report |
| Pages | 27 |
| ISBN Number | not applicable |
| Product Code | WIH00004 |
Summary
Essential research for anyone addressing one of the key challenges of today's healthcare market - how to move care to the edge of a healthcare network and relieve pressure on core services.
- Profiles of Oracle and Toumaz, IBM, Qualcomm, Card Guard, Broomwell Healthwatch and Vitaphone.
- Using remote diagnostics to disrupt the healthcare market.
- Delivering ehealth to consumers that incumbent healthcare providers ignore.
- Marketing ehealth services and devices to next generation healthcare providers.
- Remote diagnosis and for preventative healthcare.
- Moving beyond the call centre with automated diagnosis.
- Remote diagnosis and for preventative healthcare.
- Monitoring epidemics and other public health threats.
- Opportunities for ehealth providers, IT vendors and mobile operators.
Innovations in personalised healthcare and a growing interest in healthcare related consumer electronics will help ehealth providers to build and market services that disrupt the business models of incumbent healthcare providers.
The market for wireless based ehealth monitoring and diagnostics services is currently being driven by the incumbent healthcare provider desire to push key elements of the care process out towards the edge of their healthcare network. Health providers cutting costs by treating the patient remotely, rather than within a bricks and mortar hospital, has provided the basis for a number of ehealth trials and is contributing to the revenues of ehealth service providers such as Card Guard and Vitaphone.
However existing services tend only to address the healthcare needs of patients who are already receiving treatment. This report identifies an emerging ehealth model; one that is better equipped to intercept people before they enter the healthcare system. Technologies being developed by IT vendors such as Oracle and IBM will become key enablers of this new ehealth model. As well electronics companies who are attempting to shift medical device technology into the mainstream consumer electronics market are also playing an important role. Also highlighted is a growing market for end to end managed wireless and mobile connections such as Qualcomm's QConnect.
The current generation of ehealth providers often compromise their service model by working closely with incumbent healthcare providers. eHealth service providers will need to decide whether to persist with their existing ehealth model, or to take a new and more disruptive approach to the market. This report sees a plateau in the market for call centre based services as users migrate to cheaper online options. The report also notes that the adoption of automated medical diagnostic software will accelerate as ehealth service providers realise that centre operations will not scale economically to support thousands of patients.
The report also explains the difficulties next generation healthcare providers face when attempting to enter the ehealth market and examines the potential role of pharmaceutical retailers as ehealth providers. An analysis of the strategic issues facing the UK based retail pharmacist Boots Plc, which is attempting to diversify into health provision, is included in this report.
The report also points to important applications of remote monitoring and diagnostics in the monitoring of epidemics and other threats to public health.
Who should purchase this report:-
- IT and medical device vendors.
- Wireless technology vendors.
- eHealth and healthcare providers.
- Decision makers in the public healthcare sector.
- Investors in the healthcare IT sector.
- Mobile operators.
- Other organisations active in ehealth provision.
Supplied free with this report is Healthware - Wearable Computers in Healthcare, which provides an overview of the potential market for wearable computers in healthcare applications.
Wireless Healthcare reports, written for organisations who wish to exploit the growing market for networked ehealth, include:-
- Market analysis.
- Profiles of existing or potential vendors.
- Descriptions of relevant technology.
Content
- Overview
- 1 Introduction - An Ideal eHealth Model
- 2 Barriers To Adoption
- 3 The Current eHealth Model
- 3.1 Limitations Of The Current Model
- 3.1.1 Devices
- 3.1.2 Data Pipes
- 3.1.3 Automated Response And Diagnostics
- 3.1.4 Marketability
- 3.1 Limitations Of The Current Model
- 4 A Typical eHealth Service
- 4.1 Working Within Limits
- 4.1.1 Limit The Range Of Diagnostic Tests
- 4.1.2 Employ Simple Communications Platforms
- 4.1.3 Build Own Patient Record Systems
- 4.1.4 Adopt Call Centre Based Model
- 4.1.5 Partner With Health Insurers
- 4.2 The Absence Of Disruption
- 4.2.1 Working In A Heavily Regulated Market
- 4.2.2 Limitation Of Call Centre Based Models
- 4.1 Working Within Limits
- 5 eHealth As A Disruptive Process
- 6 Boots eHealth - A Missed Opportunity?
- 7 A New Model And New Challenges
- 7.1 Taming The Device Market
- 7.2 Improving Data Transport
- 7.3 Deploying Electronic Patient Records
- 7.4 Moving Beyond The Call Centre
- 7.5 Bringing Remote Diagnosis To The Market
- 8 Epidemic Monitoring And Control
- 9 Conclusions
- 10 Vendor Profiles
- Qualcomm
- Card Guard
- Vitaphone
- Broomwell Healthwatch
- Oracle
- IBM
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















